甲基泼尼松龙琥珀酸钠

更新时间：2024-01-02 14:54:12

甲基泼尼松龙琥珀酸钠结构式	常用名	甲基泼尼松龙琥珀酸钠	英文名	6alpha-Methylprednisolone sodium succinate
	CAS号	2375-03-3	分子量	496.525
	密度	N/A	沸点	689.6ºC at 760mmHg
	分子式	C₂₆H₃₃NaO₈	熔点	N/A
	MSDS	中文版美版	闪点	230.7ºC
	符号	GHS08	信号词	Danger

甲基泼尼松龙琥珀酸钠用途

6α-Methylprednisolone 21-hemisuccinate钠盐是一种糖皮质激素, 半衰期较Prednisolone长,是一种有效的抗炎剂。

中文名	甲基泼尼松龙琥珀酸钠
英文名	6α-Methylprednisolone 21-hemisuccinate sodium salt
中文别名	甲强龙琥珀酸钠 \| 6α-甲基泼尼松龙半瑚珀酸酯
英文别名	更多

描述	6α-Methylprednisolone 21-hemisuccinate钠盐是一种糖皮质激素, 半衰期较Prednisolone长,是一种有效的抗炎剂。
相关类别	信号通路 >> 其他 >> 其他研究领域 >> 炎症/免疫

沸点	689.6ºC at 760mmHg
分子式	C₂₆H₃₃NaO₈
分子量	496.525
闪点	230.7ºC
精确质量	496.207306
PSA	141.03000
LogP	0.88460
外观性状	冻干的粉末
储存条件	-20°C，密闭，干燥

甲基泼尼松龙琥珀酸钠MSDS英文版

甲基泼尼松龙琥珀酸钠毒性英文版

符号	GHS08
信号词	Danger
危害声明	H351-H360
警示性声明	P201-P281-P308 + P313
个人防护装备	Eyeshields;full-face particle respirator type N100 (US);Gloves;respirator cartridge type N100 (US);type P1 (EN143) respirator filter;type P3 (EN 143) respirator cartridges
危害码 (欧洲)	T: Toxic;
风险声明 (欧洲)	R61;R40
安全声明 (欧洲)	53-22-36/37/39-45
危险品运输编码	NONH for all modes of transport
WGK德国	3
RTECS号	TU4154060

Shoe contact dermatitis: a case report of an acute severe reaction to potassium dichromate.

Foot (Edinb.) 22(3) , 141-5, (2012)

Shoe contact dermatitis is common in both the pediatric and the adult populations. Severity of the reaction can vary greatly by patient.Health Care Professionals of all types should be familiar with s...

Ex vivomodels to evaluate the role of ocular melanin in trans-scleral drug delivery

Eur. J. Pharm. Sci. 46(5) , 475-83, (2012)

Trans-scleral delivery is nowadays considered as a possible way to deliver drugs to the posterior segment of the eye. Despite the potentiality of this administration route, there is a lack of fundamen...

Efficacy of intraoperative, single-bolus corticosteroid administration to prevent postoperative acute respiratory failure after oesophageal cancer surgery.

Interact. Cardiovasc. Thorac. Surg. 15(4) , 639-43, (2012)

Respiratory failure from acute lung injury (ALI), acute respiratory distress syndrome (ARDS) and pneumonia are the major cause of morbidity and mortality following an oesophagectomy for oesophageal ca...

MFCD00152612

11b,17,21-Trihydroxy-6a-methylpregna-1,4-diene-3,20-dione 21-(Sodium Succinate)

butanedioic acid, mono[(6α,11β)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl] ester, monosodium salt

4-{2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-triméthyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodécahydro-3H-cyclopenta[a]phénanthrén-17-yl]-2-oxoéthoxy}-4-oxobutanoate de sodium

6alpha-Methylprednisolone sodium succinate

Sodium 4-{[(6α,11β)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl]oxy}-4-oxobutanoate

6a-Methylprednisolone 21-succinate sodium

EINECS 219-156-8

Methylprednisolone sodium succinate

Natrium-4-{2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy}-4-oxobutanoat

Butanedioic acid, mono[(6α,11β)-11,17-dihydroxy-6-methyl-3,20-dioxopregna-1,4-dien-21-yl] ester, sodium salt (1:1)

sodium 4-{2-[(6S,8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-6,10,13-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl]-2-oxoethoxy}-4-oxobutanoate

6α-Methylprednisolone 21-hemisuccinate (sodium salt)